U.S. Markets open in 8 hrs 49 mins

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.69-0.34 (-4.90%)
At close: 04:00PM EST
6.76 +0.07 (+1.05%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.03
Bid6.72 x 1800
Ask6.74 x 4000
Day's Range6.53 - 6.94
52 Week Range4.86 - 24.90
Avg. Volume3,588,350
Market Cap789.179M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.46
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 09, 2012
1y Target Est12.50
  • American City Business Journals

    Oral Covid vaccine hopeful acquires 2nd manufacturing facility

    The South San Francisco company, which has expanded its real estate footprint this year, had been working with Kindred Biosciences since spring 2020 on manufacturing its experimental Covid vaccine tablet.

  • GlobeNewswire

    Vaxart Announces Acquisition of Second GMP Manufacturing Facility

    Purchase expected to give Vaxart greater control over manufacturing schedulesSOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) has entered into an agreement with Kindred Bioscience, Inc. (“KindredBio”) for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing facility in Burlingame, California, giving Vaxart control of its second GMP manufacturing facility. The transaction closed Tuesday,

  • GlobeNewswire

    Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2021 on November 30, 2021

    SOUTH SAN FRANCISCO, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that Dr. Sean Tucker, SVP and Chief Scientific Officer, will present at the World Vaccine & Immunotherapy Congress West Coast 2021 in San Diego on Tuesday, November 30, 2021 at 2:40 p.m. PT. Dr. Tucker will provide an overview of Vaxart’s development program for its oral tablet COVID-19 vaccine candidate. Vaxart’s oral tablet COVID-19 vaccine is the only oral COVID-19 vaccine about which th